-
公开(公告)号:US11141412B2
公开(公告)日:2021-10-12
申请号:US16535107
申请日:2019-08-08
Applicant: PRILENIA NEUROTHERAPEUTICS LTD.
Inventor: Malle Schmidt , Malle Pari , Marit Laos , Ants Maasalu , Kalle Kaljuste
IPC: A61K31/451 , C07D211/52 , C07D211/24 , C07D211/42 , G01N30/88
Abstract: This invention provides an isolated compound having the structure: or a salt thereof, processes for making the same and to compositions comprising pridopidine with these compounds.
-
公开(公告)号:US10406145B2
公开(公告)日:2019-09-10
申请号:US16150977
申请日:2018-10-03
Applicant: PRILENIA NEUROTHERAPEUTICS LTD.
Inventor: Malle Schmidt , Malle Päri , Marit Laos , Ants Maasalu , Kalle Kaljuste
IPC: A61K31/451 , G01N30/88 , C07D211/24 , C07D211/52 , C07D211/42
Abstract: This invention provides an isolated compound having the structure: or a salt thereof. The invention also provides for a process for preparing 4-(3-(methylsulfonyl)phenyl)-1-propylpiperidin-4-ol, 1-(3,3-bis(3-(methylsulfonyl)phenyl)propyl)-4-(3-(methylsulfonyl) phenyl)piperidone, 1,4-bis((3-(1-propylpiperidin-4-yl)phenyl)sulfonyl)butane, (3R,4S)-4-(3-(methylsulfonyl)phenyl)-1-propylpiperidin-3-ol, 4-(3-(methylsulfonyl)phenyl)-1-propylpiperidine 1-oxide, 1-(2-methylpentyl)-4-(3-(methylsulfonyl)phenyl)piperidine, 4-(3-(methylsulfinyl)phenyl)-1-propyl-1,2,3,6-tetrahydropyridine, and 4-(3-(methylsulfonyl)phenyl)-1-propyl-1,2,3,6-tetrahydropyridine.This invention also provides an impurity or a salt thereof for use, as a reference standard to detect trace amounts of the impurity in a pharmaceutical composition comprising pridopidine or a pharmaceutically acceptable salt thereof. This invention further provides a process for producing a pridopidine drug product comprising obtaining a pridopidine drug substance and. mixing the pridopidine drug substance with suitable excipients so as to produce the pridopidine drug product. This invention also provides a process for producing a pridopidine drug product. This invention also provides a process of distributing a pridopidine drug product.
-